9
项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的临床试验 / Unknown status临床1/2期IIT Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. It is Self Funded (Patients' Own Funding) Clinical Trial
This study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone Marrow Derived Autologous mono nuclear cells (100 Million per dose).trial to be conducted for 36 months in patients with diabetes Mellitus in India,Primary outcome measure are abolition or reduction of insulin by>50 percentage by the end of 6 months of ABMSCT-Any reduction in requirement of Insulin dosage and Improvement in HbA1C Level.
/ Unknown status临床1/2期IIT A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke. It is Self Funded (Patients' Own Funding) Clinical Trial
This study is single, centre trial to study the safety and efficacy of Bone marrow derived autologous MNCS(100 million per dose)trial to be conducted for 36 months in stroke patients , the primary outcome measure will be the improvement in muscle power of Body and face
/ Unknown status临床1/2期IIT A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism. It is Self Funded (Patients' Own Funding) Clinical Trial
This clinical trial is a single Arm, single centre to check the safety and efficacy of bone marrow derived autologous mono nuclear cells (MNC) (100 million per dose). Trial to be conducted for 36 months.
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的临床结果
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的转化医学
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的专利（医药）
100 项与 Bone Marrow Derived Autologous Stem Cells(Chaitanya Hospital) 相关的药物交易
